INS and diabetes mellitus: Beta-cells are very sensitive to diabetes-associated inflammatory mediators and in turn activate a series of molecular mechanisms which can lead to (i) beta-cell dysfunction (e.g., reduced insulin secretion or insulin content); (ii) beta-cell apoptosis; (iii) exacerbation of inflammatory phenomena through the secretion of chemokines which lead to an increased immune cell infiltrate.